FLIGHT THERAPEUTICS
LIVE

Serial Number

50038830

Owner

Beam Therapeutics Inc.

Attorney

John V. Hobgood, Esquire

Filing Date

Aug 7, 2026

Add to watchlist:

No watchlists yet
View on USPTO

FLIGHT THERAPEUTICS Trademark

Serial Number: 50038830

FLIGHT THERAPEUTICS is a trademark filed by Beam Therapeutics Inc. on August 7, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Beam Therapeutics Inc. (10 trademarks)

Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

August 7, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for gene therapy and gene editing; Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene therapy, genome editing, genome modification, cell therapy, cellular modification, and tissue modification for use in human therapeutics for the treatment of Myelodysplastic syndromes

Testing, inspection, research, and development of pharmaceutical preparations for gene therapy and gene editing; medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; Scientific and medical research in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification; providing scientific and medical research information, and bioinformatic algorithms and models in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification; scientific study and research in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification to develop human pharmaceutical and biological preparations

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 7, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2026 NWOS
NEW APPLICATION ENTERED
Aug 7, 2026 NWAP